Amylin receptor agonist: difference between revisions
Diff·revision 11 → 12·03:33, 19 Feb 2025
Difference between revision 11 and revision 12 of Amylin receptor agonist. 6 lines changed; the page grew by 90 bytes.
| Revision 11 — 17:27, 31 Jan 2025 MissedDoseMik (talk) fix a broken wikilink 3,532 bytes ±0 | Revision 12 — 03:33, 19 Feb 2025 CommaCarys (talk) the storage condition applies to the unopened pen; say so 3,622 bytes +90 | ||
|---|---|---|---|
| 30 | <ref name="lau2021">Lau DCW, Erichsen L, Francisco AM, et al. "Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled trial." ''The Lancet'' 398(10317):2160–2172 (2021). PMID 34798060.</ref> | 30 | <ref name="lau2021">Lau DCW, Erichsen L, Francisco AM, et al. "Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled trial." ''The Lancet'' 398(10317):2160–2172 (2021). PMID 34798060.</ref> |
| 31 | 31 | ||
| + | 32 | == See also == | |
| + | 33 | * [[Amylin]] | |
| + | 34 | * [[Cagrilintide]] | |
| + | 35 | * [[CagriSema]] | |
| + | 36 | * [[Peptide aggregation]] | |
| + | 37 | ||
| 32 | {{DEFAULTSORT:Amylin receptor agonist}} | 38 | {{DEFAULTSORT:Amylin receptor agonist}} |
| 33 | [[Category:Amylin analogues]] | 39 | [[Category:Amylin analogues]] |